Moreover, since GPC3 was detected in HCC cells but not in benign liver tumors such as dysplastic nodules, it has potential as a biomarker for the diagnosis of early stage HCC [33,34,35]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.